CL2013002370A1 - Celulas de b. texasporus de esporulacion deficiente y procedimientos para la inactivacion eficiente y de bajo costo y usuos relacionados - Google Patents
Celulas de b. texasporus de esporulacion deficiente y procedimientos para la inactivacion eficiente y de bajo costo y usuos relacionadosInfo
- Publication number
- CL2013002370A1 CL2013002370A1 CL2013002370A CL2013002370A CL2013002370A1 CL 2013002370 A1 CL2013002370 A1 CL 2013002370A1 CL 2013002370 A CL2013002370 A CL 2013002370A CL 2013002370 A CL2013002370 A CL 2013002370A CL 2013002370 A1 CL2013002370 A1 CL 2013002370A1
- Authority
- CL
- Chile
- Prior art keywords
- texasporus
- inactivation
- procedures
- cells
- efficient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Food Science & Technology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161447703P | 2011-03-01 | 2011-03-01 | |
| US13/406,202 US8673290B2 (en) | 2011-03-01 | 2012-02-27 | Sporulation-deficient B. texasporus cells and methods for efficient and cost-effective inactivation and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013002370A1 true CL2013002370A1 (es) | 2014-04-04 |
Family
ID=46753436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2013002370A CL2013002370A1 (es) | 2011-03-01 | 2013-08-16 | Celulas de b. texasporus de esporulacion deficiente y procedimientos para la inactivacion eficiente y de bajo costo y usuos relacionados |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8673290B2 (es) |
| EP (2) | EP3002340A1 (es) |
| JP (1) | JP5970483B2 (es) |
| KR (1) | KR20140015356A (es) |
| CN (2) | CN103732734B (es) |
| AR (1) | AR088715A1 (es) |
| AU (1) | AU2012223481B2 (es) |
| BR (1) | BR112013021892B1 (es) |
| CA (1) | CA2828541C (es) |
| CL (1) | CL2013002370A1 (es) |
| CO (1) | CO6751281A2 (es) |
| MX (1) | MX350277B (es) |
| RU (1) | RU2013137673A (es) |
| WO (1) | WO2012118845A1 (es) |
| ZA (1) | ZA201306276B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6345186B2 (ja) * | 2012-12-17 | 2018-06-20 | エムワイギャラクシー リミテッド カンパニー | 肥満および関連疾患の治療剤としてのｂｔリポペプチドの使用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4302544A (en) | 1979-10-15 | 1981-11-24 | University Of Rochester | Asporogenous mutant of B. subtilis for use as host component of HV1 system |
| US4450235A (en) | 1982-04-21 | 1984-05-22 | Cpc International Inc. | Asporogenic mutant of bacillus subtilis useful as a host in a host-vector system |
| US4450236A (en) | 1982-04-21 | 1984-05-22 | Cpc International Inc. | Asporogenic mutant of Bacillus subtilis useful as a host in a host-vector system |
| US4465773A (en) | 1982-04-21 | 1984-08-14 | Cpc International Inc. | Amylase-negative, asporogenous mutant of Bacillus subtilis useful as a host in a host-vector system |
| US5480641A (en) | 1990-06-15 | 1996-01-02 | Biogaia Ab | Feed additive which consists of whey and Lactobacillus reuteri and a method of delivering Lactobacillus reuteri to the gastrointestinal tract |
| IT1244477B (it) * | 1990-12-21 | 1994-07-15 | Eniricerche Spa | Ceppo asporigeno di bacillus subtilis e suo impiego come ospite per la preparazione di prodotti eterologhi |
| WO2004095941A1 (en) | 2003-04-28 | 2004-11-11 | Alpharma, Inc. | Method for formulation of microbial feed additives with feed |
| US7655452B1 (en) | 2003-11-11 | 2010-02-02 | Higeta Shoyu Co., Ltd. | Brevibacillus choshinensis and process for prodcuing protein wtih use of the microbe as host |
| CA2554634A1 (en) * | 2004-01-30 | 2005-08-18 | The Texas A & M University System | Compositions, methods and uses for a novel family of peptides |
| JP2010220539A (ja) * | 2009-03-24 | 2010-10-07 | Tosoh Corp | 胞子形成能が欠損した細菌、及びそれを用いたタンパク質製造方法 |
-
2012
- 2012-02-27 US US13/406,202 patent/US8673290B2/en active Active
- 2012-02-28 AU AU2012223481A patent/AU2012223481B2/en not_active Ceased
- 2012-02-28 CN CN201280020898.8A patent/CN103732734B/zh active Active
- 2012-02-28 MX MX2013009993A patent/MX350277B/es active IP Right Grant
- 2012-02-28 BR BR112013021892-4A patent/BR112013021892B1/pt not_active IP Right Cessation
- 2012-02-28 EP EP15196151.3A patent/EP3002340A1/en not_active Withdrawn
- 2012-02-28 CN CN201510993878.4A patent/CN105567587A/zh active Pending
- 2012-02-28 EP EP12712165.5A patent/EP2681338B1/en not_active Not-in-force
- 2012-02-28 JP JP2013556816A patent/JP5970483B2/ja not_active Expired - Fee Related
- 2012-02-28 WO PCT/US2012/026999 patent/WO2012118845A1/en active Application Filing
- 2012-02-28 KR KR1020137023142A patent/KR20140015356A/ko not_active Application Discontinuation
- 2012-02-28 CA CA2828541A patent/CA2828541C/en not_active Expired - Fee Related
- 2012-02-28 RU RU2013137673/10A patent/RU2013137673A/ru not_active Application Discontinuation
- 2012-03-01 AR ARP120100673A patent/AR088715A1/es unknown
-
2013
- 2013-08-16 CL CL2013002370A patent/CL2013002370A1/es unknown
- 2013-08-20 ZA ZA2013/06276A patent/ZA201306276B/en unknown
- 2013-08-28 CO CO13204350A patent/CO6751281A2/es unknown
-
2014
- 2014-02-13 US US14/179,926 patent/US20140162343A1/en not_active Abandoned
- 2014-02-13 US US14/179,933 patent/US20140199753A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2013009993A (es) | 2013-12-06 |
| CN105567587A (zh) | 2016-05-11 |
| US8673290B2 (en) | 2014-03-18 |
| CN103732734A (zh) | 2014-04-16 |
| CN103732734B (zh) | 2016-01-20 |
| AU2012223481A1 (en) | 2013-08-29 |
| US20140162343A1 (en) | 2014-06-12 |
| US20120225037A1 (en) | 2012-09-06 |
| AR088715A1 (es) | 2014-07-02 |
| WO2012118845A1 (en) | 2012-09-07 |
| RU2013137673A (ru) | 2015-04-10 |
| JP5970483B2 (ja) | 2016-08-17 |
| CA2828541C (en) | 2020-04-21 |
| US20140199753A1 (en) | 2014-07-17 |
| AU2012223481B2 (en) | 2016-06-30 |
| CO6751281A2 (es) | 2013-09-16 |
| BR112013021892A2 (pt) | 2016-09-06 |
| EP3002340A1 (en) | 2016-04-06 |
| CA2828541A1 (en) | 2012-09-07 |
| EP2681338A1 (en) | 2014-01-08 |
| JP2014512807A (ja) | 2014-05-29 |
| MX350277B (es) | 2017-08-30 |
| ZA201306276B (en) | 2016-07-27 |
| EP2681338B1 (en) | 2015-11-25 |
| KR20140015356A (ko) | 2014-02-06 |
| BR112013021892B1 (pt) | 2021-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2505123B (en) | Social media identity discovery and mapping | |
| CL2015001666A1 (es) | Preparación de éteres de poli-alfa-1,3-glucano | |
| DK2726145T3 (da) | Minimalt invasivt, dermalt elektroporationsapparat | |
| CO6811868A2 (es) | Combinaciones de principios activos | |
| EP2748781A4 (en) | TWO FACTOR IDENTITY FINGER PRINTING PROCEDURES WITH USER BEHAVIOR | |
| BR112015002868A2 (pt) | dispositivos, sistemas e métodos para se engajar tecido | |
| BR112015006198A2 (pt) | conjunto de cadeira | |
| DK3432649T3 (da) | Radionetværksknude, brugerindretning og fremgangsmåder dertil | |
| DK2837680T3 (da) | Mammaliacellekultur | |
| DK2882850T3 (da) | System for preparation of adipose-derived stem cells | |
| DK2620428T3 (da) | Asymmetrisk hjælpegruppe | |
| CO6960510A2 (es) | Celdas fotocatalíticas mejoradas | |
| DK2861711T3 (da) | Engangsbioreaktor og hovedplade, og en fremgangsmåde til fremstilling deraf | |
| GB2512003B (en) | Physical mapping of wireless networks | |
| EP2659332A4 (en) | Wireless ad-hoc network facilitating social interactions among plurality of users | |
| FR2994831B1 (fr) | Prothese de main. | |
| DK2772001T3 (da) | Dynamisk krypteringsfremgangsmåde | |
| FI20126195A (fi) | Menetelmä, järjestely ja hissijärjestelmä | |
| BR112014026557A2 (pt) | fralda descartável. | |
| BR112014020372A8 (pt) | n-etil-n-fenil-1,2-di-hidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, preparação e utilização do mesmo | |
| DK2914574T3 (da) | Ny fremgangsmåde | |
| GB2507970B (en) | Self-configuration of wireless networks | |
| BR112014010432A2 (pt) | uso médico | |
| CL2013002370A1 (es) | Celulas de b. texasporus de esporulacion deficiente y procedimientos para la inactivacion eficiente y de bajo costo y usuos relacionados | |
| DK2446780T3 (da) | Stol, især kontorstol |